1-6 of 6
Jörg Schubert, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic Stem Cell Transplantation for Hodgkin's Disease From Sibling and Unrelated Donors: The German Cooperative Transplantation Study Group Experience.

Christof Scheid, Peter Dreger, Dietrich W. Beelen, Martin Bornhäuser, Matthias Stelljes, Nikolaus Kröger, Max Topp, Gernot Stuhler, Ralf G Meyer, Wolfgang Andreas Bethge, MD, Jörg Schubert, MD, Rainer Schwerdtfeger, MD, Igor W. Blau, William Hermann Krüger, Lutz Uharek, Michael Stadler, MD, Hans Martin, MD, Ralph Naumann, MD, Peter Borchmann, Michael Hallek, Andreas Engert
Journal: Blood
Blood (2009) 114 (22): 2293.
https://doi.org/10.1182/blood.V114.22.2293.2293
Published: 2009
Journal Articles

Rituximab for Graft-Versus-Host-Disease-Prophylaxis after Allogeneic Stem Cell Transplantation Given as Treatment of High Risk Relapse of Aggressive Lymphoma: Results of a Randomized Phase II Study.

Bertram Glass, MD, Justin Hasenkamp, MD, Anke Görlitz, Peter Dreger, MD, Jörg Schubert, MD, Gerald Wulf, MD, Maike Nickelsen, MD, Lorenz H. Truemper, MD, Norbert Schmitz, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1974.
https://doi.org/10.1182/blood.V112.11.1974.1974
Published: 2008
Journal Articles

Sustained Improvements in Transfusion Requirements, Fatigue and Thrombosis with Eculizumab Treatment in Paroxysmal Nocturnal Hemoglobinuria.

Gerard Socié, MD, PhD, Peter Hillmen, MB ChB, Petra Muus, MD, PhD, Jörg Schubert, MD, Ulrich Dührsen, DM, Antonio M. Risitano, MD PhD, Russell P. Rother, PhD, Robert A. Brodsky, MD, Jeffrey Szer, MB BS
Journal: Blood
Blood (2007) 110 (11): 3672.
https://doi.org/10.1182/blood.V110.11.3672.3672
Published: 2007
Journal Articles

The Terminal Complement Inhibitor Eculizumab Reduces Thrombosis in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Peter Hillmen, MB, PhD, Petra Muus, MD, PhD, Ulrich Dührsen, DM, Antonio M. Risitano, MD, PhD, Jörg Schubert, MD, Neal S. Young, MD, Hubert Schrezenmeier, MD, Jeffrey Szer, MB, BS, Robert A. Brodsky, MD, Anita Hill, MB, MD, Gérard Socié, MD, PhD, Scott A. Rollins, PhD, Russell P. Rother, PhD, Leonard Bell, MD, Lucio Luzzatto, MD
Journal: Blood
Blood (2006) 108 (11): 123.
https://doi.org/10.1182/blood.V108.11.123.123
Published: 2006
Journal Articles

Treatment with the Terminal Complement Inhibitor Eculizumab Improves Anemia in Patients with Paroxysmal Nocturnal Hemoglobinuria: Phase III Triumph Study Results.

Jörg Schubert, MD, Peter Hillmen, MB, PhD, Ulrich Dührsen, DM, Neal S. Young, MD, Modupe Elebute, MB, MD, Jeffrey Szer, MB, BS, Giacomo Gianfaldoni, MD, Gérard Socié, MD, PhD, Paul Browne, MD, Christopher F. Mojcik, MD, PhD, Russell P. Rother, PhD, Petra Muus, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 124.
https://doi.org/10.1182/blood.V108.11.124.124
Published: 2006
Journal Articles

Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Interim Shepherd Phase III Clinical Study.

Neal S. Young, MD, Elisabetta Antonioli, MD, Bruno Rotoli, MD, Hubert Schrezenmeier, MD, Jörg Schubert, MD, Alvaro Urbano-Ispizua, MD, Luke Coyle, MD, Carlos de Castro, MD, Chieh-Lin Fu, MD, Jaroslaw P. Maciejewski, MD, PhD, Christopher F. Mojcik, MD, PhD, Russell P. Rother, PhD, Peter Hillmen, MB PhD
Journal: Blood
Blood (2006) 108 (11): 971.
https://doi.org/10.1182/blood.V108.11.971.971
Published: 2006